Transcatheter Valve SELECTion in Patients With Right Bundle Branch Block and Impact on Pacemaker Implantations.

[1]  Adnan Kastrati,et al.  Evaluación multicéntrica del sobredimensionamiento de la prótesis transcatéter SAPIEN 3. Impacto en el fallo del dispositivo y nuevos implantes de marcapasos , 2019, Revista Española de Cardiología.

[2]  Adnan Kastrati,et al.  Predictores de necesidad de marcapasos permanente y alteraciones de la conducción con el implante transcatéter de una nueva válvula aórtica autoexpandible , 2019, Revista Española de Cardiología.

[3]  T. Bilfinger,et al.  Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. , 2018, Journal of the American College of Cardiology.

[4]  Jeroen J. Bax,et al.  Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review , 2018, European heart journal.

[5]  T. Kuntze,et al.  Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  C. Hamm,et al.  Outcome after transvascular transcatheter aortic valve implantation in 2016 , 2017, European heart journal.

[7]  R. Kobza,et al.  Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[8]  C. Hengstenberg,et al.  Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves. , 2017, JACC. Cardiovascular interventions.

[9]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[10]  P. Lemos,et al.  Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement. , 2017, JACC: Cardiovascular Interventions.

[11]  T. Walther,et al.  Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family. , 2017, JACC. Cardiovascular interventions.

[12]  S. Kapadia,et al.  Clinical and Echocardiographic Outcomes Following Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: Meta-Analysis and Meta-Regression , 2017, Circulation. Cardiovascular interventions.

[13]  P. Stella,et al.  Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre‐Existent Right Bundle Branch Block , 2017, Journal of the American Heart Association.

[14]  M. Dalby,et al.  Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry. , 2017, JACC. Cardiovascular interventions.

[15]  A. Olowoyeye,et al.  Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. , 2016, JACC. Cardiovascular interventions.

[16]  S. Rosenkranz,et al.  Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3. , 2016, JACC. Cardiovascular interventions.

[17]  P. Wenaweser,et al.  Repositionable Versus Balloon‐Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis , 2016, Journal of the American Heart Association.

[18]  T. Walther,et al.  Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[19]  W. Rottbauer,et al.  Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[20]  J. Leipsic,et al.  Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. , 2016, European heart journal.

[21]  J. Leipsic,et al.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.

[22]  H. Baumgartner,et al.  Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height. , 2016, JACC. Cardiovascular interventions.

[23]  S. Redwood,et al.  Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve: United Kingdom Experience. , 2016, JACC. Cardiovascular interventions.

[24]  C. Hengstenberg,et al.  Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve. , 2016, JACC. Cardiovascular interventions.

[25]  Angelo B. Biviano,et al.  Chronic pacing and adverse outcomes after transcatheter aortic valve implantation , 2015, Heart.

[26]  G. Gerosa,et al.  Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[27]  J. Andrade,et al.  Electrocardiographic and electrophysiological predictors of atrioventricular block after transcatheter aortic valve replacement. , 2015, Heart rhythm.

[28]  M. Mack,et al.  Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. , 2015, JACC. Cardiovascular interventions.

[29]  Peter Jüni,et al.  Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. , 2014, Journal of the American College of Cardiology.

[30]  J. Webb,et al.  Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation Impact on Late Clinical Outcomes and Left Ventricular Function , 2022 .

[31]  J. Kempfert,et al.  Symetis ACURATE TF™ aortic bioprosthesis. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  J. Leipsic,et al.  Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. , 2013, JACC. Cardiovascular interventions.

[33]  S. Achenbach,et al.  SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). , 2012, Journal of cardiovascular computed tomography.

[34]  P. Boekstegers,et al.  Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. , 2012, Journal of the American College of Cardiology.

[35]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[36]  A. Cook,et al.  Permanent Pacemaker Insertion After CoreValve Transcatheter Aortic Valve Implantation: Incidence and Contributing Factors (the UK CoreValve Collaborative) , 2011, Circulation.

[37]  P. D. de Jaegere,et al.  Electrocardiographic and further predictors for permanent pacemaker requirements after transcatheter aortic valve implantation. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[38]  C. Hamm,et al.  Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.